Eli Lilly has Launched Zepbound in U.S. Pharmacies. The company enters the booming weight-loss market with a potential $2 billion sales projection. NTD’s Stephanie Sical reports.
Eli Lilly Projects $2 Billion In Sales for 2024
By NTD Newsroom
Eli Lilly has Launched Zepbound in U.S. Pharmacies. The company enters the booming weight-loss market with a potential $2 billion sales projection. NTD’s Stephanie Sical reports.